• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰分离株的系统进化关系:耐多药病例中出现北京基因型。

Phylogenetic relationships of isolates in Poland: The emergence of Beijing genotype among multidrug-resistant cases.

机构信息

Department of Medical Microbiology, Institute of Microbiology, University of Warsaw, Faculty of Biology, Warsaw, Poland.

Department of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, Warsaw, Poland.

出版信息

Front Cell Infect Microbiol. 2023 Mar 16;13:1161905. doi: 10.3389/fcimb.2023.1161905. eCollection 2023.

DOI:10.3389/fcimb.2023.1161905
PMID:37009494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10061152/
Abstract

INTRODUCTION

The epidemiological situation of tuberculosis (TB) in Poland urges for its continuous and scrupulous monitoring. The objective of this study was to explore the genetic diversity of multidrug-resistant (MDR) and drug-susceptible (DS) isolates from Poland with a combination of spoligotyping and high-resolution mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) analysis. The results were placed in the Northern and Eastern Europe context.

METHODS

The study included 89 (39 MDR and 50 DS) isolates collected from as many patients between 2018 and 2021 in Poland. The analysis was done using spoligotyping, and MIRU-VNTR typing at 24 standard loci. The data were compared to those available on Poland and neighbors and global datasets.

RESULTS

The main identified families were Beijing (28.1%) and Haarlem (16.8%) while 34.8% of isolates were in the heterogeneous L4-unclassified group. Although the Beijing family was the most prevalent (61.5%) among MDR-TB cases, it accounted for only 2% of DS isolates. Among foreign-born patients, a higher ratio of MDR isolates were observed when compared with those who Poland-born (64.3% vs. 40%). Furthermore, all patients from the Former Soviet Union (FSU) countries were infected with MDR-TB.

DISCUSSION

Whereas DS population in Poland is dominated by L4 isolates, MDR isolates are mostly of the Beijing genotype. The rise in the prevalence of the Beijing isolates in Poland, coupled with high proportion of the Beijing genotype among foreign-born TB patients may reflect an ongoing transmission of this family, imported to Poland mainly from FSU countries.

摘要

简介

波兰的结核病(TB)流行情况需要持续和细致的监测。本研究的目的是通过 spoligotyping 和高分辨率分枝杆菌间隔重复单元-可变数量串联重复(MIRU-VNTR)分析,探索来自波兰的耐多药(MDR)和敏感(DS)分离株的遗传多样性,并将结果置于北欧和东欧的背景下。

方法

该研究纳入了 2018 年至 2021 年期间从波兰 89 名患者(39 名 MDR 和 50 名 DS)中收集的分离株。使用 spoligotyping 和 24 个标准位点的 MIRU-VNTR 分型进行分析。将数据与波兰及其邻国和全球数据集进行比较。

结果

主要鉴定的家族是北京家族(28.1%)和 Haarlem 家族(16.8%),而 34.8%的分离株属于异质 L4 未分类组。虽然北京家族是 MDR-TB 病例中最常见的(61.5%),但它仅占 DS 分离株的 2%。在外国出生的患者中,MDR 分离株的比例高于波兰出生的患者(64.3%对 40%)。此外,所有来自前苏联(FSU)国家的患者均感染了 MDR-TB。

讨论

尽管波兰的 DS 人群主要由 L4 分离株主导,但 MDR 分离株主要为北京基因型。北京分离株在波兰的流行率上升,以及外国出生的结核病患者中北京基因型的比例较高,可能反映了该家族的持续传播,主要从 FSU 国家传入波兰。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/dbfdb188d59f/fcimb-13-1161905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/a1eb6ffb8ae7/fcimb-13-1161905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/90f92d2be3fd/fcimb-13-1161905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/dbfdb188d59f/fcimb-13-1161905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/a1eb6ffb8ae7/fcimb-13-1161905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/90f92d2be3fd/fcimb-13-1161905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/10061152/dbfdb188d59f/fcimb-13-1161905-g003.jpg

相似文献

1
Phylogenetic relationships of isolates in Poland: The emergence of Beijing genotype among multidrug-resistant cases.波兰分离株的系统进化关系:耐多药病例中出现北京基因型。
Front Cell Infect Microbiol. 2023 Mar 16;13:1161905. doi: 10.3389/fcimb.2023.1161905. eCollection 2023.
2
Genetic Diversity of Mycobacterium tuberculosis Isolates from Assam, India: Dominance of Beijing Family and Discovery of Two New Clades Related to CAS1_Delhi and EAI Family Based on Spoligotyping and MIRU-VNTR Typing.印度阿萨姆邦结核分枝杆菌分离株的遗传多样性:基于间隔寡核苷酸分型(Spoligotyping)和多位点可变数目串联重复序列分型(MIRU-VNTR)分型的北京家族优势及与CAS1_德里和EAI家族相关的两个新分支的发现
PLoS One. 2015 Dec 23;10(12):e0145860. doi: 10.1371/journal.pone.0145860. eCollection 2015.
3
Molecular Epidemiology and Genetic Diversity of Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh.孟加拉国耐多药结核分枝杆菌分离株的分子流行病学和遗传多样性。
Microbiol Spectr. 2022 Feb 23;10(1):e0184821. doi: 10.1128/spectrum.01848-21.
4
Insight into multidrug-resistant Beijing genotype Mycobacterium tuberculosis isolates in Myanmar.缅甸耐多药北京基因型结核分枝杆菌分离株的研究进展。
Int J Infect Dis. 2018 Nov;76:109-119. doi: 10.1016/j.ijid.2018.06.009. Epub 2018 Jun 21.
5
Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.中国一家三级结核病防治医院中耐多药和广泛耐药结核病的基因分型和临床特征。
BMC Infect Dis. 2013 Jul 12;13:315. doi: 10.1186/1471-2334-13-315.
6
Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates in Punjab, Pakistan.巴基斯坦旁遮普邦耐多药结核分枝杆菌分离株的遗传多样性。
Infect Genet Evol. 2019 Aug;72:16-24. doi: 10.1016/j.meegid.2019.02.029. Epub 2019 Feb 26.
7
Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.巴西米纳斯吉拉斯州耐多药结核分枝杆菌的遗传多样性与分子流行病学
BMC Infect Dis. 2015 Aug 1;15:306. doi: 10.1186/s12879-015-1057-y.
8
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.W-北京型和非北京型结核分枝杆菌亚谱系感染的肺结核患者的社会人口学和临床特征比较
Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23.
9
Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.基于 spoligotype 的波兰耐多药和异烟肼单耐药结核分枝杆菌复合临床分离株的比较种群结构分析。
J Clin Microbiol. 2010 Nov;48(11):3899-909. doi: 10.1128/JCM.00572-10. Epub 2010 Sep 1.
10
Tuberculosis - A global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage.结核病——全球紧急情况:监测、理解和控制疫情的工具与方法,以北京家族分支为例
Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S177-89. doi: 10.1016/j.tube.2015.02.023. Epub 2015 Feb 13.

引用本文的文献

1
Molecular typing of Mycobacterium tuberculosis: a review of current methods, databases, softwares, and analytical tools.结核分枝杆菌的分子分型:当前方法、数据库、软件及分析工具综述
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf017.
2
Letter to the Editor: First detection of a XDR clinical isolate harbouring an RpoB I491F mutation in a Ukrainian patient treated in Germany, October 2023.致编辑的信:2023年10月,在德国接受治疗的一名乌克兰患者中首次检测到携带RpoB I491F突变的广泛耐药临床分离株。
Euro Surveill. 2024 Oct;29(42). doi: 10.2807/1560-7917.ES.2024.29.42.2400665.
3
Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine.

本文引用的文献

1
Genetic Diversity and Primary Drug Resistance of Beijing Genotype Strains in Northwestern Russia.俄罗斯西北部北京基因型菌株的遗传多样性和原发性耐药性
Microorganisms. 2023 Jan 19;11(2):255. doi: 10.3390/microorganisms11020255.
2
Tuberculosis in Poland: Epidemiological and Molecular Analysis during the COVID-19 Pandemic.波兰的结核病:新冠疫情期间的流行病学与分子分析
Diagnostics (Basel). 2022 Aug 3;12(8):1883. doi: 10.3390/diagnostics12081883.
3
Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis.
推进结核病管理:预测性、预防性和个性化医学的作用。
Front Microbiol. 2023 Oct 4;14:1225438. doi: 10.3389/fmicb.2023.1225438. eCollection 2023.
摩尔多瓦结核分枝杆菌的系统地理学和传播:一项前瞻性的基因组分析。
PLoS Med. 2022 Feb 22;19(2):e1003933. doi: 10.1371/journal.pmed.1003933. eCollection 2022 Feb.
4
Practical approach to detection and surveillance of emerging highly resistant Mycobacterium tuberculosis Beijing 1071-32-cluster.实用方法检测和监测新兴高度耐药结核分枝杆菌北京 1071-32 簇。
Sci Rep. 2021 Nov 1;11(1):21392. doi: 10.1038/s41598-021-00890-7.
5
COVID-19 in Patients with Active Tuberculosis.活动性肺结核患者中的新型冠状病毒肺炎
Diagnostics (Basel). 2021 Sep 26;11(10):1768. doi: 10.3390/diagnostics11101768.
6
Emergence of multidrug-resistant of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing.葡萄牙和几内亚比绍出现具有北京谱系的耐多药结核分枝杆菌:全基因组测序揭示移动克隆。
Emerg Microbes Infect. 2020 Dec;9(1):1342-1353. doi: 10.1080/22221751.2020.1774425.
7
Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.2015 年,乌克兰出现了耐多种药物和广泛耐药结核分枝杆菌北京家族。
Emerg Infect Dis. 2020 Mar;26(3):481-490. doi: 10.3201/eid2603.190525.
8
Molecular study of mycobacterial strains prevalent in the Czech Republic in 2014.2014年捷克共和国流行的分枝杆菌菌株的分子研究。
Epidemiol Mikrobiol Imunol. 2019 Winter;68(3):131-136.
9
Analysis of Mycobacterium tuberculosis genetic lineages circulating in Riga and Riga region, Latvia, isolated between 2008 and 2012.分析 2008 年至 2012 年间在拉脱维亚里加和里加地区分离的结核分枝杆菌遗传谱系。
Infect Genet Evol. 2020 Mar;78:104126. doi: 10.1016/j.meegid.2019.104126. Epub 2019 Nov 26.
10
Severe Clinical Outcomes of Tuberculosis in Kharkiv Region, Ukraine, Are Associated with Beijing Strains of Mycobacterium tuberculosis.乌克兰哈尔科夫地区结核病的严重临床结果与结核分枝杆菌的北京菌株有关。
Pathogens. 2019 Jun 10;8(2):75. doi: 10.3390/pathogens8020075.